title: Usefulness of the percentage of plasma lymphocytes as a prognostic marker in patients with congestive heart failure.
abstract: This prospective study was designed to evaluate the prognostic value of the percentage of plasma lymphocytes in patients with diastolic dysfunction as well as systolic dysfunction of the left ventricle. The subjects were 70 consecutive patients who were hospitalized in our institution from April 2001 to August 2002. Following the improvement of congestive heart failure, leukocyte differentiation and neurohumoral factors (plasma levels of atrial and brain natriuretic peptide, norepinephrine, epinephrine, and dopamine) were measured. During the follow-up period (17 +/- 9 months), 18 patients experienced a cardiac event. In the univariate analysis, the percentage of plasma lymphocytes in the cardiac event group was significantly less than that in the noncardiac event group (24.7 +/- 8.40 vs 33.3 +/- 7.64%, P = 0.0006), and brain natriuretic peptide was significantly larger in the cardiac event group (402 +/- 168 vs 153 +/- 51 pg/mL, P = 0.04). However, in patients with preserved systolic function, there was a significant difference in the percentage of plasma lymphocytes between the cardiac and noncardiac event groups (21.7 +/- 9.42 vs 34.2 +/- 8.21%, P = 0.037), although no difference was observed in brain natriuretic peptide (133 +/- 43 vs 125 +/- 50 pg/mL, P = 0.87). Multivariate analysis showed the percentage of plasma lymphocytes was an independent predictor of a cardiac event. The percentage of plasma lymphocytes may be useful for predicting the course of patients with congestive heart failure based on diastolic dysfunction as well as systolic dysfunction.
authors.affiliation: Department of Cardiology, Matsushita Memorial Hospital, Osaka, Japan.
authors.forename: Tomohiko
authors.initials: T
authors.lastname: Sakatani
authors.forename: Mitsuyoshi
authors.initials: M
authors.lastname: Hadase
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Kawasaki
authors.forename: Tadaaki
authors.initials: T
authors.lastname: Kamitani
authors.forename: Shingo
authors.initials: S
authors.lastname: Kawasaki
authors.forename: Hiroki
authors.initials: H
authors.lastname: Sugihara
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001281:Atrial Fibrillation / Q000150:complications; D015415:Biomarkers / Q000097:blood; D002395:Catecholamines / Q000097:blood; D005260:Female; D006333:Heart Failure / Q000097:blood* / Q000503:physiopathology; D006801:Humans; D018655:Lymphocyte Count; D008297:Male; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010949:Plasma / Q000166:cytology*; D011379:Prognosis; D011446:Prospective Studies; D013599:Systole; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis*
chemical_list: D015415:Biomarkers; D002395:Catecholamines; D020097:Natriuretic Peptide, Brain